Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Chimerix Inc (CMRX)

Chimerix Inc (CMRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
8.54 -0.01 (-0.12%) 04/17/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 8.54 unch (unch) 18:10 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
8.54
Day High
8.55
Open 8.55
Previous Close 8.55 8.55
Volume 755,500 755,500
Avg Vol 1,972,935 1,972,935
Stochastic %K 96.30% 96.30%
Weighted Alpha +176.00 +176.00
5-Day Change +0.01 (+0.12%) +0.01 (+0.12%)
52-Week Range 0.75 - 8.55 0.75 - 8.55
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 801,086
  • Shares Outstanding, K 93,804
  • Annual Sales, $ 210 K
  • Annual Income, $ -88,390 K
  • EBIT $ -97 M
  • EBITDA $ -100 M
  • 60-Month Beta -0.17
  • Price/Sales 3,783.13
  • Price/Cash Flow N/A
  • Price/Book 6.32
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.99
  • Most Recent Earnings $-0.25 on 03/21/25
  • Next Earnings Date 05/07/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 19.20% ( -0.95%)
  • Historical Volatility 2.33%
  • IV Percentile 11%
  • IV Rank 0.23%
  • IV High 532.16% on 11/15/24
  • IV Low 18.03% on 03/25/25
  • Put/Call Vol Ratio 0.62
  • Today's Volume 708
  • Volume Avg (30-Day) 295
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 18,452
  • Open Int (30-Day) 18,787

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.27
  • Number of Estimates 2
  • High Estimate -0.26
  • Low Estimate -0.27
  • Prior Year -0.25
  • Growth Rate Est. (year over year) -8.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.46 +0.95%
on 04/07/25
Period Open: 8.47
8.55 -0.12%
on 04/17/25
+0.07 (+0.83%)
since 03/17/25
3-Month
3.43 +148.97%
on 01/21/25
Period Open: 3.55
8.55 -0.12%
on 04/17/25
+4.99 (+140.56%)
since 01/17/25
52-Week
0.75 +1,038.67%
on 08/13/24
Period Open: 0.90
8.55 -0.12%
on 04/17/25
+7.64 (+844.69%)
since 04/17/24

Most Recent Stories

More News
Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?

While JAZZ Pharmaceuticals JAZZ may not be a typical cannabis stock, it is the only company to market an FDA-approved drug that contains a purified drug substance derived from marijuana.The company entered...

JAZZ : 100.34 (-2.37%)
TLRY : 0.4476 (-0.53%)
CMRX : 8.54 (-0.12%)
JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell?

Share price of JAZZ Pharmaceuticals JAZZ hit $102.82 on Tuesday, close to its 52-week low of $99.06.This decline is attributable to the significant downturn in the broader biotech/drug sector due to the...

JAZZ : 100.34 (-2.37%)
EBS : 4.54 (-1.73%)
CMRX : 8.54 (-0.12%)
Chimerix: Q4 Earnings Snapshot

Chimerix: Q4 Earnings Snapshot

CMRX : 8.54 (-0.12%)
Chimerix Reports Fourth Quarter and Year End 2024 Financial Results

CMRX : 8.54 (-0.12%)
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CMRX : 8.54 (-0.12%)
Investors Hit the Jackpot! 8 Micro, Small, and Mid-Cap Stocks That Went Through the Roof

The broader stock market faced renewed selling pressure today, with major indices experiencing sharp declines. The Dow Jones Industrial Average plunged 500 points, extending its recent losing streak as...

CDXC : 7.87 (-0.88%)
MP : 23.19 (-11.99%)
PRTS : 0.7800 (-3.14%)
TNXP : 14.96 (-4.77%)
SITM : 126.57 (-2.24%)
ARBB : 0.7326 (-3.61%)
CMRX : 8.54 (-0.12%)
GV : 1.88 (-8.74%)
Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio

Jazz Pharmaceuticals JAZZ announced that it has entered into a definitive agreement to acquire all the outstanding shares of clinical-stage biotech Chimerix CMRX for $8.55 per share in cash, aggregating...

JAZZ : 100.34 (-2.37%)
EBS : 4.54 (-1.73%)
CMRX : 8.54 (-0.12%)
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

JAZZ : 100.34 (-2.37%)
CMRX : 8.54 (-0.12%)
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CMRX : 8.54 (-0.12%)
Chimerix Announces FDA Acceptance and Priority Review of New Drug Application for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma

CMRX : 8.54 (-0.12%)

Business Summary

Chimerix is a biopharmaceutical company which develop medicines for lives of patients facing deadly diseases. The Company's most advanced clinical-stage development program ONC201, is in development for H3 K27M-mutant glioma. Chimerix is based in DURHAM, N.C.

See More

Key Turning Points

3rd Resistance Point 8.56
2nd Resistance Point 8.55
1st Resistance Point 8.55
Last Price 8.54
1st Support Level 8.54
2nd Support Level 8.53
3rd Support Level 8.53

See More

52-Week High 8.55
Last Price 8.54
Fibonacci 61.8% 5.57
Fibonacci 50% 4.65
Fibonacci 38.2% 3.73
52-Week Low 0.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro